Sally M Hartwick, Md Pllc | |
25 Evergreen St Afton NY 13730-2129 | |
(607) 316-1576 | |
Not Available |
Full Name | Sally M Hartwick, Md Pllc |
---|---|
Speciality | Family Medicine |
Location | 25 Evergreen St, Afton, New York |
Authorized Official Name and Position | Sally Hartwick (OWNER) |
Authorized Official Contact | 6076392701 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Sally M Hartwick, Md Pllc 25 Evergreen St Afton NY 13730-2129 Ph: (607) 639-2701 | Sally M Hartwick, Md Pllc 25 Evergreen St Afton NY 13730-2129 Ph: (607) 316-1576 |
NPI Number | 1205410784 |
---|---|
Provider Enumeration Date | 05/10/2021 |
Last Update Date | 12/03/2021 |
Medicare PECOS PAC ID | 1759786817 |
---|---|
Medicare Enrollment ID | O20210827000588 |
News Archive
Patient engagement is considered a key priority In today's healthcare services, both in the context of improved effectiveness of treatment and information technology.
People with symptoms of Alzheimer's disease, such as cognitive difficulties, behavior changes and mood swings, may wait months or even years to get a definitive diagnosis. That's because doctors lack a simple, accurate and inexpensive test for it.
HealthLeaders-InterStudy and Fingertip Formulary find that 70 percent of surveyed pharmacy directors expect to cover Pfizer's tanezumab if it is approved for the treatment of chronic pain. Tanezumab, which is expected to be the first biologic approved for chronic pain and is administered intravenously under medical supervision, will likely be covered as a medical benefit rather than a pharmacy benefit according to surveyed pharmacy directors.
Eurofins Optimed Clinical Research, an experienced European clinical research service provider and Spaulding Clinical Research, LLC., US-based, leading-edge Clinical Pharmacology, Cardiac Core Lab, and Medical Device Manufacturer, announce a joint partnership agreement.
› Verified 6 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1205410784 | NPI | - | NPPES |
1275023020 | Other | TYPE 1 NPI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | (* (Not Available)) | Primary |
Provider Name | Stephen L Dygert |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1508844929 PECOS PAC ID: 8325015753 Enrollment ID: I20110322000714 |
News Archive
Patient engagement is considered a key priority In today's healthcare services, both in the context of improved effectiveness of treatment and information technology.
People with symptoms of Alzheimer's disease, such as cognitive difficulties, behavior changes and mood swings, may wait months or even years to get a definitive diagnosis. That's because doctors lack a simple, accurate and inexpensive test for it.
HealthLeaders-InterStudy and Fingertip Formulary find that 70 percent of surveyed pharmacy directors expect to cover Pfizer's tanezumab if it is approved for the treatment of chronic pain. Tanezumab, which is expected to be the first biologic approved for chronic pain and is administered intravenously under medical supervision, will likely be covered as a medical benefit rather than a pharmacy benefit according to surveyed pharmacy directors.
Eurofins Optimed Clinical Research, an experienced European clinical research service provider and Spaulding Clinical Research, LLC., US-based, leading-edge Clinical Pharmacology, Cardiac Core Lab, and Medical Device Manufacturer, announce a joint partnership agreement.
› Verified 6 days ago
Provider Name | Sally Hartwick |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1275023020 PECOS PAC ID: 2668877721 Enrollment ID: I20210827000660 |
News Archive
Patient engagement is considered a key priority In today's healthcare services, both in the context of improved effectiveness of treatment and information technology.
People with symptoms of Alzheimer's disease, such as cognitive difficulties, behavior changes and mood swings, may wait months or even years to get a definitive diagnosis. That's because doctors lack a simple, accurate and inexpensive test for it.
HealthLeaders-InterStudy and Fingertip Formulary find that 70 percent of surveyed pharmacy directors expect to cover Pfizer's tanezumab if it is approved for the treatment of chronic pain. Tanezumab, which is expected to be the first biologic approved for chronic pain and is administered intravenously under medical supervision, will likely be covered as a medical benefit rather than a pharmacy benefit according to surveyed pharmacy directors.
Eurofins Optimed Clinical Research, an experienced European clinical research service provider and Spaulding Clinical Research, LLC., US-based, leading-edge Clinical Pharmacology, Cardiac Core Lab, and Medical Device Manufacturer, announce a joint partnership agreement.
› Verified 6 days ago
News Archive
Patient engagement is considered a key priority In today's healthcare services, both in the context of improved effectiveness of treatment and information technology.
People with symptoms of Alzheimer's disease, such as cognitive difficulties, behavior changes and mood swings, may wait months or even years to get a definitive diagnosis. That's because doctors lack a simple, accurate and inexpensive test for it.
HealthLeaders-InterStudy and Fingertip Formulary find that 70 percent of surveyed pharmacy directors expect to cover Pfizer's tanezumab if it is approved for the treatment of chronic pain. Tanezumab, which is expected to be the first biologic approved for chronic pain and is administered intravenously under medical supervision, will likely be covered as a medical benefit rather than a pharmacy benefit according to surveyed pharmacy directors.
Eurofins Optimed Clinical Research, an experienced European clinical research service provider and Spaulding Clinical Research, LLC., US-based, leading-edge Clinical Pharmacology, Cardiac Core Lab, and Medical Device Manufacturer, announce a joint partnership agreement.
› Verified 6 days ago
Afton Family Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 25 Evergreen Avenue, Afton, NY 13730 Phone: 607-639-2701 Fax: 607-639-3333 |